Beijing New Leading Medallion

Beijing New Leading Pharmaceutical Technology is a prominent Chinese Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) providing integrated drug development services. Founded in 2005 and headquartered in Beijing, the company offers a full suite of services including pharmaceutical chemistry, formulation development, clinical trial management, and bioequivalence studies. It operates several high-tech R&D centers and a large-scale manufacturing base in Cangzhou, focusing on both high-end generic drugs and innovative small molecule therapeutics. As a subsidiary of the publicly traded Taihe Health Technology Group, New Leading supports a global clientele through its "one-stop" R&D platform, facilitating the transition from laboratory discovery to commercial production. The company is recognized as a leading player in the Chinese pharmaceutical outsourcing market, known for its technical expertise and comprehensive regulatory support.